Tradestie Institutional Equity Comparison Engine

ALPS vs ABVC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ALPS Overall Edge

ALPS Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ALPS (ALPS) driven by superior Momentum & Technical. Fundamentally, ALPS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABVC at N/M Forward P/E and 0.0% operating margin (+104.5% YoY). In options structure, ALPS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ALPS N/M vs ABVC N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +104.5%
Momentum & Technical Winner ALPS
1Y +35.3% vs -68.2% ยท 52W Pos 51% vs 7%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ALPS US Equity
ALPS
Institutional Equity
$1.15
-3.36% 1D
Market Cap $37.7M
1M Return +250.72%
1Y Return +35.29%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 50.0 Fund 29.0 Flow 50.0 Mom 46.0
ABVC NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap $23.9M
1M Return -17.28%
1Y Return -68.15%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ALPS +35.29% ABVC -68.15% Spread: +103.44 pp (ALPS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ALPS TTM Op. Margin: 0.0% ABVC TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ALPS vs ABVC. Trailing 12-month operating profitability (ALPS 0.0% vs ABVC 0.0%) and valuation multiples (ALPS N/M vs ABVC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ALPS (3) vs ABVC (3)
Institutional Metric ALPS ABVC Criterion Row Winner
Market Capitalization Scale $37.7M $23.9M Larger Scale ALPS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +104.5% Higher Growth ABVC
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 0.0% -52.7% Higher ROE ALPS
52-Week Range Position Momentum 51% ($0โ€“$2) 7% ($1โ€“$3) Stronger Trend ALPS
Beta / 30D Volatility Risk Regime 6.25ฮฒ ยท 1362% Vol 1.24ฮฒ ยท 44% Vol Lower Realized Risk ABVC
Unified Institutional Score Composite Signal 31.6 / 100 (SELL) 47.4 / 100 (HOLD) Higher Composite ABVC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ALPS vs ABVC Buy Guide
ALPS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ALPS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABVC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ALPS nor ABVC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.